Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Reaches New 12-Month Low – Here’s What Happened

Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) reached a new 52-week low on Tuesday . The company traded as low as $4.86 and last traded at $4.88, with a volume of 2434151 shares. The stock had previously closed at $4.91.

Analyst Ratings Changes

Separately, Bank of America upgraded Bayer Aktiengesellschaft from an “underperform” rating to a “neutral” rating in a report on Friday, September 6th. Five investment analysts have rated the stock with a hold rating, Based on data from MarketBeat, Bayer Aktiengesellschaft has a consensus rating of “Hold”.

Bayer Aktiengesellschaft Stock Performance

The company has a quick ratio of 0.81, a current ratio of 1.32 and a debt-to-equity ratio of 1.19. The stock has a fifty day moving average of $5.89 and a 200-day moving average of $6.94. The firm has a market capitalization of $19.18 billion, a P/E ratio of -18.77 and a beta of 1.03.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last issued its earnings results on Tuesday, November 12th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.10). The firm had revenue of $10.96 billion during the quarter. Bayer Aktiengesellschaft had a negative net margin of 2.02% and a positive return on equity of 16.90%. On average, research analysts anticipate that Bayer Aktiengesellschaft will post 1.31 EPS for the current year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.